Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT05860465 · RECRUITING
Trial details
- NCT number
- NCT05860465
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-08
- Primary completion
- 2026-12-01
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.